578 related articles for article (PubMed ID: 19421058)
1. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents.
Brigham KS; Sandora TJ
Curr Opin Pediatr; 2009 Aug; 21(4):437-43. PubMed ID: 19421058
[TBL] [Abstract][Full Text] [Related]
2. Prevention of meningococcal disease.
Kimmel SR
Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836
[TBL] [Abstract][Full Text] [Related]
3. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
4. Neisseria meningitidis B vaccines.
Panatto D; Amicizia D; Lai PL; Gasparini R
Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal disease.
Daley AJ
Aust Fam Physician; 2003 Aug; 32(8):597-601, 603-5. PubMed ID: 12973866
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
Prasad K; Karlupia N
Respir Med; 2007 Oct; 101(10):2037-43. PubMed ID: 17706408
[TBL] [Abstract][Full Text] [Related]
7. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
Poland GA
Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
[TBL] [Abstract][Full Text] [Related]
8. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
Levy C; Taha MK; Bingen E; Cohen R;
Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
[TBL] [Abstract][Full Text] [Related]
9. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
Magdzik W
Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
[TBL] [Abstract][Full Text] [Related]
10. Conquering the meningococcus.
Stephens DS
FEMS Microbiol Rev; 2007 Jan; 31(1):3-14. PubMed ID: 17233633
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal disease.
Memish ZA; Alrajhi AA
Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
[TBL] [Abstract][Full Text] [Related]
12. Neisseria meningitidis: presentation, treatment, and prevention.
Ferguson LE; Hormann MD; Parks DK; Yetman RJ
J Pediatr Health Care; 2002; 16(3):119-24. PubMed ID: 12015670
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal vaccine in travelers.
Wilder-Smith A
Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
[TBL] [Abstract][Full Text] [Related]
14. Expanding prevention of invasive meningococcal disease.
Pelton SI; Gilmet GP
Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
[TBL] [Abstract][Full Text] [Related]
15. Meningococcal disease: risk for international travellers and vaccine strategies.
Wilder-Smith A
Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
[TBL] [Abstract][Full Text] [Related]
16. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
17. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
18. Recent trends in meningococcal epidemiology and current vaccine recommendations.
Baltimore RS
Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
[TBL] [Abstract][Full Text] [Related]
19. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.
Soriano-Gabarró M; Wolter J; Hogea C; Vyse A
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):761-74. PubMed ID: 21905785
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
